These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16201930)

  • 1. Ciprofloxacin resistance and its molecular mechanism in Campylobacter spp. isolated in Kuwait.
    Albert MJ; Neil L; Pazhoor AA; Haridas S; Rotimi VO; Khan I
    Microb Drug Resist; 2005; 11(3):266-70. PubMed ID: 16201930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of gyrA mutation among clinical isolates of Campylobacter jejuni isolated in Egypt by MAMA-PCR.
    Said MM; El-Mohamady H; El-Beih FM; Rockabrand DM; Ismail TF; Monteville MR; Ahmed SF; Klena JD; Salama MS
    J Infect Dev Ctries; 2010 Oct; 4(9):546-54. PubMed ID: 21045366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
    Bachoual R; Ouabdesselam S; Mory F; Lascols C; Soussy CJ; Tankovic J
    Microb Drug Resist; 2001; 7(3):257-61. PubMed ID: 11759087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment.
    Griggs DJ; Johnson MM; Frost JA; Humphrey T; Jørgensen F; Piddock LJ
    Antimicrob Agents Chemother; 2005 Feb; 49(2):699-707. PubMed ID: 15673754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle.
    Jesse TW; Englen MD; Pittenger-Alley LG; Fedorka-Cray PJ
    J Appl Microbiol; 2006 Apr; 100(4):682-8. PubMed ID: 16553723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure.
    Yan M; Sahin O; Lin J; Zhang Q
    J Antimicrob Chemother; 2006 Dec; 58(6):1154-9. PubMed ID: 17023497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
    McIver C; Hogan T; White P; Tapsall J
    Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High level of ciprofloxacin resistance and its molecular background among Campylobacter jejuni strains isolated in the United Arab Emirates.
    Sonnevend Á; Rotimi VO; Kolodziejek J; Usmani A; Nowotny N; Pál T
    J Med Microbiol; 2006 Nov; 55(Pt 11):1533-1538. PubMed ID: 17030913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis.
    Zirnstein G; Li Y; Swaminathan B; Angulo F
    J Clin Microbiol; 1999 Oct; 37(10):3276-80. PubMed ID: 10488192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
    Beckmann L; Müller M; Luber P; Schrader C; Bartelt E; Klein G
    J Appl Microbiol; 2004; 96(5):1040-7. PubMed ID: 15078520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli.
    Hänninen ML; Hannula M
    J Antimicrob Chemother; 2007 Dec; 60(6):1251-7. PubMed ID: 17911389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
    Pasquali F; Rossi M; Manfreda G; Zanoni R
    Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PCR-restriction fragment length polymorphism assay (PCR-RFLP) as an useful tool for detection of mutation in gyrA gene at 86-THR position associated with fluoroquinolone resistance in Campylobacter jejuni].
    Wardak S; Szych J; Cieślik A
    Med Dosw Mikrobiol; 2005; 57(3):295-301. PubMed ID: 16494206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing.
    Charvalos E; Peteinaki E; Spyridaki I; Manetas S; Tselentis Y
    J Clin Lab Anal; 1996; 10(3):129-33. PubMed ID: 8731499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SVR-flaA typing of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni strains isolated from poultry slaughterhouses in southern Brazil.
    Dias TS; de Almeida Figueira A; Costa GA; da Cunha NC; Rossi DA; de Melo RT; de Almeida Pereira VL; de Aquino MHC
    Braz J Microbiol; 2023 Jun; 54(2):1065-1073. PubMed ID: 37055624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant contribution of the CmeABC Efflux pump in high-level resistance to ciprofloxacin and tetracycline in Campylobacter jejuni and Campylobacter coli clinical isolates.
    Sharifi S; Bakhshi B; Najar-Peerayeh S
    Ann Clin Microbiol Antimicrob; 2021 May; 20(1):36. PubMed ID: 34016127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR-restriction fragment length polymorphism assay for detection of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli.
    Alonso R; Mateo E; Girbau C; Churruca E; Martinez I; Fernández-Astorga A
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4886-8. PubMed ID: 15561873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
    Ge B; McDermott PF; White DG; Meng J
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3347-54. PubMed ID: 16048946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance.
    Gibreel A; Tracz DM; Nonaka L; Ngo TM; Connell SR; Taylor DE
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3442-50. PubMed ID: 15328109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance.
    Sonnevend Á; Kovács J; Pál T; Akawi N; Nagelkerke N; Schneider G
    Scand J Infect Dis; 2011 Dec; 43(11-12):905-11. PubMed ID: 21905953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.